Kazakhstan vs Kiribati: Prevalence rate of hypertension in adults aged 30-79
Kazakhstan
41.9
in 2019
Kiribati
42.3
in 2019
Kazakhstan rank
57th
Kiribati rank
55th
Prevalence rate of hypertension in adults aged 30-79 over time
- Kazakhstan
- Kiribati
How they compare
Kiribati currently reports 42.3 against 41.9 in Kazakhstan, a difference of 0.4.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Kazakhstan ahead.
Kazakhstan ranks 57th and Kiribati ranks 55th of 194 countries.
Kazakhstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kazakhstan | Kiribati | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 39.33 | 30.53 | 8.8 | Kazakhstan |
| 2000s | 40.69 | 31.06 | 9.63 | Kazakhstan |
| 2010s | 41.93 | 38.41 | 3.52 | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in adults aged 30-79, Kazakhstan or Kiribati?
- Kiribati, at 42.3 against 41.9 in Kazakhstan as of 2019.
- What is the difference in prevalence rate of hypertension in adults aged 30-79 between Kazakhstan and Kiribati?
- 0.4, with Kiribati ahead.
- How many years of comparable data are there for Kazakhstan and Kiribati?
- 30 years are reported by both, from 1990 to 2019.
- How do Kazakhstan and Kiribati rank globally for prevalence rate of hypertension in adults aged 30-79?
- Kazakhstan ranks 57th and Kiribati ranks 55th of 194 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in adults aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of the population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.